Exicure, Inc. (XCUR)
1.15
-0.03
(-2.54%)
USD |
NASDAQ |
Oct 02, 16:00
1.16
+0.01
(+0.87%)
Pre-Market: 20:00
Exicure Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -165.8% |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 84.49% |
| September 30, 2022 | -256.0% |
| June 30, 2022 | -302.3% |
| March 31, 2022 | -325.5% |
| December 31, 2021 | -652.7% |
| September 30, 2021 | |
| June 30, 2021 | -18.06K% |
| March 31, 2021 | -1.25K% |
| December 31, 2020 | -9.06K% |
| Date | Value |
|---|---|
| September 30, 2020 | -361.1% |
| June 30, 2020 | -88.94% |
| March 31, 2020 | 12.52% |
| December 31, 2019 | -3.22K% |
| September 30, 2019 | -1.10K% |
| June 30, 2019 | -1.20K% |
| March 31, 2019 | -21.14K% |
| December 31, 2018 | -79.25K% |
| September 30, 2018 | -9.34K% |
| June 30, 2018 | -35.92K% |
| March 31, 2018 | -15.30K% |
| December 31, 2017 | -164.3% |
| September 30, 2017 | -77.37% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -10.44K% |
| Celularity, Inc. | 17.55% |
| Cardio Diagnostics Holdings, Inc. | -27.81K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -181.7% |
| Return on Assets | -56.73% |
| Return on Invested Capital | -173.8% |
| Return on Net Operating Assets | -93.61% |